Nitric oxide and mitochondria in metabolic syndrome

Larisa Litvinova, Dmitriy N. Atochin, Nikolai Fattakhov, Mariia Vasilenko, Pavel Zatolokin, Elena Kirienkova

Research output: Contribution to journalReview articlepeer-review

51 Citations (Scopus)


Metabolic syndrome (MS) is a cluster of metabolic disorders that collectively increase the risk of cardiovascular disease. Nitric oxide (NO) plays a crucial role in the pathogeneses of MS components and is involved in different mitochondrial signaling pathways that control respiration and apoptosis. The present review summarizes the recent information regarding the interrelations of mitochondria and NO in MS. Changes in the activities of different NO synthase isoforms lead to the formation of metabolic disorders and therefore are highlighted here. Reduced endothelial NOS activity and NO bioavailability, as the main factors underlying the endothelial dysfunction that occurs in MS, are discussed in this review in relation to mitochondrial dysfunction. We also focus on potential therapeutic strategies involving NO signaling pathways that can be used to treat patients with metabolic disorders associated with mitochondrial dysfunction. The article may help researchers develop new approaches for the diagnosis, prevention and treatment of MS.

Original languageEnglish
Article number20
JournalFrontiers in Physiology
Issue numberFEB
Publication statusPublished - 2015
Externally publishedYes


  • Metabolic syndrome
  • Mitochondrial dysfunction
  • Mitochondrial nitric oxide synthase
  • Nitric oxide
  • Nitric oxide synthase
  • Nitric oxide synthase type I
  • Nitric oxide synthase type II
  • Oxide synthase type III

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Nitric oxide and mitochondria in metabolic syndrome'. Together they form a unique fingerprint.

Cite this